The store will not work correctly when cookies are disabled.
3-(7-oxo-7-(pyrrolidin-1-yl)heptyl)benzoic acid
ID: ALA4467865
PubChem CID: 155532389
Max Phase: Preclinical
Molecular Formula: C18H25NO3
Molecular Weight: 303.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1cccc(CCCCCCC(=O)N2CCCC2)c1
Standard InChI: InChI=1S/C18H25NO3/c20-17(19-12-5-6-13-19)11-4-2-1-3-8-15-9-7-10-16(14-15)18(21)22/h7,9-10,14H,1-6,8,11-13H2,(H,21,22)
Standard InChI Key: ORLJMDYAJURICX-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
9.5009 -13.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2086 -13.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9163 -13.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7932 -13.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0855 -13.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3778 -13.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6700 -13.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9623 -13.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2546 -13.8138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9623 -12.5880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5047 -13.4799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9578 -14.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3665 -14.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1658 -14.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9138 -14.6321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6206 -15.0406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3293 -14.6320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3267 -13.8105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6192 -13.4057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6207 -15.8589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9128 -16.2672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3282 -16.2679 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
3 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 3 1 0
20 21 1 0
20 22 2 0
16 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.40 | Molecular Weight (Monoisotopic): 303.1834 | AlogP: 3.50 | #Rotatable Bonds: 8 |
Polar Surface Area: 57.61 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.07 | CX Basic pKa: ┄ | CX LogP: 3.54 | CX LogD: 0.42 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.75 | Np Likeness Score: -0.44 |
References
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |